Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryTargeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imagingTumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of LactaptinEvolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.Selection of phage-displayed peptides on live adherent cells in microfluidic channels.Combinatorial peptide libraries: mining for cell-binding peptides.Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1Biopanning of phage displayed peptide libraries for the isolation of cell-specific ligandsPeptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis.The role of HER2 in cancer therapy and targeted drug deliveryScreening and identification of a renal carcinoma specific peptide from a phage display peptide library.Selective DNA delivery to tumor cells using an oligoarginine-LTVSPWY peptideUsing phage as a platform to select cancer cell-targeting peptidesTumor-targeting peptides from combinatorial libraries.Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.Bioconjugation of oligonucleotides for treating liver fibrosis.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth.Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells.Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells.
P2860
Q27013843-146FD3B5-E5D1-47A8-87A0-B6F776592EC5Q28533782-39C59FC6-B721-41C2-B22A-BBA5D2FAE581Q28553463-4A60FFCC-7857-4E29-8989-D3959E47A212Q30497908-A0CD7495-1E75-453C-BE7B-90F2767D0E10Q31004986-112BC234-7353-4615-9C4F-6B0FB492A1EAQ31144876-6D48B14F-F2EE-49FE-BF85-73879AD20173Q33256392-B389F9FC-4305-4988-8A33-472A0EFCA6D0Q33401626-B4309176-E53C-4645-8542-2F36D0E5C193Q33520512-B610CABB-CC93-4FDF-A9E6-87BB497835D4Q33811185-307B34BE-63F5-4C74-9CB1-DA3330A58E43Q34031434-9BFB17E5-312A-4B7A-856E-E9713F984D65Q34054213-295FD1D3-06FD-4A2A-A4AA-68A58D8A8768Q34070986-FB7AAFF2-F40A-4E3B-B952-B7619152F8A6Q34388329-1CEC2A04-ECEF-4307-B4A8-0493CAE78F70Q34889444-F9971DE1-3613-411B-BF36-0B61F4380C7AQ36025723-E7ABE052-AC1E-4D27-BDCC-C576D28D19D8Q36136306-C4BCD0D9-C16C-495B-AEF9-656A95CDA330Q36191982-2F403A6D-2D8A-4129-8F67-AA85213CD6CEQ37043515-CE14D901-6342-4448-A211-3929455914E8Q37346447-E8F09D34-39F6-4330-A93B-6CA1CB921C1CQ37689046-37D748EB-C0C8-4BF7-BA99-D18449F3699FQ38718538-E2213D2D-2311-4DBA-B418-2CBCE5CDF3CCQ41851061-CF484B78-1FEF-475C-88EC-A755374F4A68
P2860
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of novel carrie ...... herapeutics into cancer cells.
@ast
Identification of novel carrie ...... herapeutics into cancer cells.
@en
type
label
Identification of novel carrie ...... herapeutics into cancer cells.
@ast
Identification of novel carrie ...... herapeutics into cancer cells.
@en
prefLabel
Identification of novel carrie ...... herapeutics into cancer cells.
@ast
Identification of novel carrie ...... herapeutics into cancer cells.
@en
P356
P1433
P1476
Identification of novel carrie ...... herapeutics into cancer cells.
@en
P2093
Mohsen Shadidi
Mouldy Sioud
P304
P356
10.1096/FJ.02-0280FJE
P407
P577
2002-12-18T00:00:00Z